Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Spectral AI ( (MDAI) ) has issued an announcement.
Spectral AI announced it has regained compliance with Nasdaq’s listing standards, eliminating the need for further review. This milestone reflects the company’s dedication to meeting regulatory requirements and supports its ongoing advancements, including an upcoming FDA submission, reinforcing its commitment to innovation in the medical diagnostics field.
More about Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company specializing in medical diagnostics to enhance wound care treatment decisions. Their primary product, the DeepView® System, utilizes multi-spectral imaging and algorithms to forecast burn healing potential, aiming to improve patient outcomes and reduce healthcare costs.
YTD Price Performance: -23.17%
Average Trading Volume: 1,981,514
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $40.17M
For detailed information about MDAI stock, go to TipRanks’ Stock Analysis page.
